Guardant Health
GH
#1160
Rank
NZ$35.45 B
Marketcap
NZ$267.38
Share price
-1.60%
Change (1 day)
213.02%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): NZ-$5.79

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is NZ-$5.99. In 2025 the company made an earnings per share (EPS) of NZ-$5.85 an increase over its 2024 EPS that were of NZ-$6.29.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$5.79-0.98%
2025NZ-$5.85-7.02%
2024NZ-$6.29-16.82%
2023NZ-$7.56-33.13%
2022NZ-$11.3160%
2021NZ-$7.0755.04%
2020NZ-$4.56207.14%
2019NZ-$1.48-19.81%
2018NZ-$1.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
NZ-$4.96-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
NZ-$4.38-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA